# FDA Inspection 1155320 - Novartis d.o.o. - September 11, 2020

Source: https://www.keypedia.com/records/fda_inspections/novartis-doo/4bf055c1-d709-40df-8e9a-cbe4a310aab7
Source feed: FDA_Inspections

> FDA Inspection 1155320 for Novartis d.o.o. on September 11, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155320
- Company Name: Novartis d.o.o.
- Inspection Date: 2020-09-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1228827 - 2022-09-21](https://www.keypedia.com/records/fda_inspections/novartis-doo/b39c80f5-1389-4298-b973-b1a35ed7a319)
- [FDA Inspection 1004338 - 2017-02-13](https://www.keypedia.com/records/fda_inspections/novartis-doo/38a4ae18-3dc8-44f3-b5b6-f35e81024ba2)
- [FDA Inspection 945699 - 2015-09-18](https://www.keypedia.com/records/fda_inspections/novartis-doo/07caa49c-41cb-4df6-8475-3dfb733b37a8)
- [FDA Inspection 807398 - 2012-10-19](https://www.keypedia.com/records/fda_inspections/novartis-doo/1f734843-6120-4d60-a253-2ffff3ce7d17)
- [FDA Inspection 605785 - 2009-08-12](https://www.keypedia.com/records/fda_inspections/novartis-doo/2c463818-4c0e-46cb-ae7f-ccabe358fe47)

Company: https://www.keypedia.com/companies/novartis-doo/55471e35-a203-4edf-a4b9-fe1ad0bb16fd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c